
LABP
Healthcare · Biotechnology · $71.7M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2024
EPS trend, 90 days to now · +30.8% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 9, 2024 | Before the open | -1.00 | -1.43 | -43.0% |
| Mar 21, 2024 | Before the open | -0.91 | -0.99 | -8.8% |
| Nov 9, 2023 | Before the open | -0.88 | -0.94 | -6.8% |
| Aug 9, 2023 | Before the open | -1.10 | -0.63 | +42.7% |
| May 12, 2023 | Before the open | -0.09 | -0.09 | 0.0% |
| Mar 23, 2023 | Before the open | -0.19 | -0.13 | +31.6% |
| Nov 10, 2022 | Before the open | -0.28 | -0.20 | +28.6% |
| Aug 11, 2022 | Before the open | -0.36 | -0.28 | +22.2% |
| May 12, 2022 | After the close | -0.35 | -0.37 | -5.7% |
| Mar 24, 2022 | After the close | -0.33 | -0.40 | -21.2% |
| Nov 15, 2021 | Before the open | -0.44 | -0.32 | +27.3% |
| Jul 29, 2021 | Before the open | -0.14 | 0.12 | +185.7% |
| May 17, 2021 | Before the open | -0.37 |
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. Its lead product candidate is NX-13, an oral gut-selective Nucleotide Oligomerization Domain (NLRX1), a mitochondria-associated receptor associated with the modulation of inflammatory cytokines that is in Phase 2 clinical trial to treat ulcerative colitis (UC) and…
| -0.38 |
| -2.7% |
| Mar 31, 2021 | After the close | -0.69 | -0.91 | -31.9% |
| Dec 1, 2020 | Time not confirmed | — | -0.09 | — |
| Sep 1, 2020 | Time not confirmed | — | -0.18 | — |
| Jun 30, 2020 | Time not confirmed | 0.00 | -0.44 | — |
| Mar 31, 2020 | Time not confirmed | 0.00 | -0.44 | — |
| Sep 30, 2019 | Time not confirmed | 0.00 | -0.27 | — |
| Jun 30, 2019 | Time not confirmed | 0.00 | -0.31 | — |
| Mar 31, 2019 | Time not confirmed | 0.00 | -0.31 | — |